Geoffrey Crouse

2015

In 2015, Geoffrey Crouse earned a total compensation of $3M as Former President and Chief Executive Officer of Cord Blood Registry at AMAG Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$155,000
Option Awards$994,144
Salary$225,030
Stock Awards$1,172,625
Other$500,000
Total$3,046,799

Crouse received $1.2M in stock awards, accounting for 38% of the total pay in 2015.

Crouse also received $155K in non-equity incentive plan, $994.1K in option awards, $225K in salary and $500K in other compensation.

Rankings

In 2015, Geoffrey Crouse's compensation ranked 3,127th out of 13,638 executives tracked by ExecPay. In other words, Crouse earned more than 77.1% of executives.

ClassificationRankingPercentile
All
3,127
out of 13,638
77th
Division
Manufacturing
1,117
out of 5,190
79th
Major group
Chemicals And Allied Products
409
out of 1,854
78th
Industry group
Drugs
322
out of 1,528
79th
Industry
Pharmaceutical Preparations
257
out of 1,182
78th
Source: SEC filing on April 15, 2016.

Crouse's colleagues

We found six more compensation records of executives who worked with Geoffrey Crouse at AMAG Pharmaceuticals in 2015.

2015

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2015

Julie Krop

AMAG Pharmaceuticals

Chief Medical Officer

2015

Frank Thomas

AMAG Pharmaceuticals

Chief Operating Officer

2015

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

2015

Kenneth Wilson

AMAG Pharmaceuticals

Former Senior Vice President, Sales and Marketing, and President of Lumara Health Division

2015

Scott Holmes

AMAG Pharmaceuticals

Chief Accounting Officer

You may also like